Research suggests no need for yellow fever vaccine booster after initial dose

Research shows a single yellow fever vaccine provides lifelong immunity, with breakthrough infections being rare, supporting WHO guidelines on vaccination.

GSK’s RSV vaccine Arexvy shows long-term protection in Phase 3 trial

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 9, 2024

White House launches permanent pandemic office

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new

July 21, 2023

Sage ‘encouraged’ by initial Zurzuvae sales in postpartum depression, but no word on major depression plans

Doctors ordered 120 prescriptions of Zurzuvae, the new pill for postpartum depression, in the final days of December once the drug became available, its manufacturer

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.